Arbor Rapha Capital Bioholdings Corp. I

Arbor Rapha Capital Bioholdings Corp. I (Nasdaq: ARCK) is a blank-check company formed by sponsor Arbor Rapha Capital to pursue an acquisition in the healthcare and life sciences sector. The company completed its initial public offering in 2021, targeting biotechnology and biopharmaceutical businesses as potential combination partners. The SPAC filed an 8-K with the Securities and Exchange Commission on March 7, 2023 (accession no. 0001104659-23-029550), reflecting a material corporate development during its search for a qualifying target. ARCK represents the first special purpose acquisition vehicle launched under the Arbor Rapha Capital platform. For comprehensive data on ARCK, including filing history, shareholder votes, and deal timelines, sign up for full access at SpacDesk.